Through comprehensive IHC profiling, recurrence of plasmacytic myeloma was ruled out, ultimately leading to the diagnosis of SMARCB1 (INI-1)-deficient intrathoracic neoplasm of the lung. The gene discussed is SMARCB1; the disease is lung neoplasm.